Maculaser, a company developing treatments for retinal disorders that affect millions of people worldwide and that currently have no effective […]
Maculaser receives Instrumentarium Science Foundation grant Read more ›
Maculaser’s novel temperature-controlled subthreshold laser therapy and method for treating diabetic macular edemas is currently being presented at the world’s leading
Maculaser showcased in PhotonicsWest BIOS Read more ›
Maculaser’s Chief Scientific Officer Teemu Turunen presented the results of our clinical usability trial in Visionarium XX, an acknowledged conference
Maculaser in Visionarium XX, conference for wide-scope vision research Read more ›
The start of the autumn has been filled with both ophthalmology and investment events. Latest, the past two days in
Nordic Life Science Days – A rising star Read more ›
This study introduces a new method for monitoring and controlling the temperature of the retina during laser treatments, using a
A study describes the basis of retinal temperature monitoring for clinical use Read more ›
Marja Pitkänen’s doctoral thesis at Aalto University, defended on June 12, 2020, presents a groundbreaking exploration in the field of
Dissertation pioneers the use of ERG as a retinal temperature monitor Read more ›
The paper explores a new laser-induced heat treatment method for the retina, focusing on inducing a protective response in the
Induction of protective response with heat treatment shown in mouse RPE Read more ›
The study presents a new method for real-time monitoring of retinal temperature in living mice using electroretinography (ERG), a technique
An in vivo proof-of-concept in monitoring retinal temperature in mice Read more ›
The study introduces an innovative method for determining retinal temperature in mice using electroretinography (ERG), which records the retina’s response
Principles of retinal temperature monitoring demonstrated in isolated mouse retinas Read more ›
